Hair loss treatment: Japan's Aderans signs deal with U.S. startup

Stemson Therapeutics to take over Japanese company's American research

20240308N Aderans

U.S.-based Stemson Therapeutics will take over research started by Aderans. (Aderans)

SEIYA OTA, Nikkei staff writer

TOKYO -- Japanese hair care company Aderans will grant intellectual property rights for its hair restoration research to a U.S. biotech startup, with an eye to future collaboration on treatments for pattern baldness and other conditions.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.